Requiron Medtech LLP - healthcare in New Delhi, Delhi, India. FY 2026 financials & compliance.
LLPIN AAM-4384 Incorporated 17 April 2018 ROC Delhi HQ New Delhi, Delhi, India
Active Limited Liability Partnership healthcare
Data last updated
Revenue · FY 2022
₹4.89 Lakh
▼ 12% YoY
Net profit · FY 2022
₹12,965
Net margin 2.7%
EBITDA · FY 2022
-₹4.7 Lakh
EBITDA margin -96.1%
Contribution obligation
₹1 Cr
As per LLP agreement
Open charges
₹1 Cr
Secured borrowings
LLP age
8 yrs
Est. 2018
Designated partners
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date

About Requiron Medtech LLP

Data last updated:

Requiron Medtech LLP is a limited liability partnership (LLP) based in New Delhi, Delhi, India. It operates in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 17 April 2018 and has been in existence for over 8 years.

The LLP is registered with the Registrar of Companies (ROC), Delhi, under LLPIN AAM-4384.

The LLP has a total obligation of contribution of ₹1 Cr. It is led by designated partners Abhishek Chander and Pratul Nayar.

Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at F – 11 S/F 2nd Floor East Of Kailash Near Big Apple, New Delhi, Delhi, India – 110065.

As per the financials filed for FY 2022, the LLP reported a revenue of ₹4.89 Lakh, a decline of 12% compared to the previous year. For the same year it recorded a net profit of ₹12,965 (net margin 2.7%) and EBITDA of -₹4.7 Lakh (EBITDA margin -96.1%). Revenue has declined at a compounded annual rate (CAGR) of 15% over three years.

As per MCA filings, the LLP has open charges of ₹1 Cr on record.

Company details

LLPIN AAM-4384
Incorporation Date 17 April 2018
Total Obligation of Contribution ₹1 Cr
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 31 March 2025
Date of Balance Sheet 31 March 2025

Contact details

Requiron Medtech LLP's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.

  • Email
  • Registered Address
    F – 11 S/F 2nd Floor East Of Kailash Near Big Apple, New Delhi, Delhi, India – 110065
  • Industry
    Healthcare, Medical & Laboratory Equipment

To see the full contact details of Requiron Medtech LLP, buy the company report.

Comprehensive company report
Requiron Medtech LLP - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Requiron Medtech LLP

FY 2025 filings available

Requiron Medtech LLP reported revenue of ₹4.89 Lakh (down 12% YoY) for FY 2022.

Revenue · FY 2022
₹4.89 Lakh ▼ 12%
Net profit · FY 2022
₹12,965 margin 2.7%
EBITDA · FY 2022
-₹4.7 Lakh margin -96.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 12%
3 years · compounded
▼ 15%

Revenue has declined at a compounded annual rate (CAGR) of 15% over three years, including a 12% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

Statement of Account and SolvencyFY 2021-22FY 2020-21FY 2019-20FY 2018-19
Income and Expenditure
Turnover
Other Income
Total Income₹4.89 Lakh
Purchases and Direct Costs
Personnel Expenses
Administrative Expenses
Interest
Depreciation
Total Expenses
Profit Before Tax
Tax
Profit After Tax₹12,965
Profit Transferred to Partners
Assets and Liabilities
Partners' Contribution
Reserves and Surplus
Secured Loans
Unsecured Loans
Trade Payables
Other Liabilities and Provisions
Total Liabilities
Fixed Assets
Investments
Loans and Advances
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

Statement of Account and SolvencyFY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profitability
Net Profit Margin2.7%
Return on Partners' Funds
Return on Assets
Liquidity and Debt
Current Ratio
Debt to Partners' Funds
Interest Coverage
Efficiency and Growth
Asset Turnover
Receivable Days
Turnover Growth
Profit Growth

To see the full financial statements and ratios of Requiron Medtech LLP, buy the company report.

Designated partners of Requiron Medtech LLP

Requiron Medtech has 2 current designated partners and 4 former designated partners. Current designated partners are listed first, with their designation and appointment date.

Current Designated Partners
NameDesignationAppointment DateTenureStatus
Abhishek ChanderDesignated Partner19 Feb 20242 Years 8 MonthsCurrent
Pratul NayarDesignated Partner19 Feb 20242 Years 8 MonthsCurrent

Charges & borrowings

Open charges
₹1 Cr
Satisfied charges
None
Breakdown by lending institutions
Hdfc Bank Limited₹1.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
18 Oct 2024101007700Hdfc Bank Limited₹1 CrOpen

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Requiron Medtech LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Requiron Medtech LLP; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Requiron Medtech LLP has 10 designated partner changes on record since 2024: 6 appointments and 4 cessations. The latest: Aashima Chander was appointed as Partner on 19 Feb 2024.

AGM
Requiron Medtech Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records.
Filing
Requiron Medtech Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 1.00 Cr with Charge ID 101007700 was registered on 18 Oct 2024.
Appointed
Aashima Chander was appointed as Partner.
Appointed
Abhishek Chander was appointed as Designated Partner.
Appointed
Atula Nayar was appointed as Partner.
Appointed
Deepak Chander was appointed as Partner.
Appointed
Parveen Nayar was appointed as Partner.
Appointed
Pratul Nayar was appointed as Designated Partner.
Ceased
Aashima Chander ceased to be Designated Partner.
Ceased
Atula Nayar ceased to be Designated Partner.
Ceased
Deepak Chander ceased to be Designated Partner.

2 earlier events are in the company report.

Frequently asked questions

Requiron Medtech is an active limited liability partnership based in New Delhi, Delhi, India. The LLP works in medical and laboratory equipment, within the healthcare industry. It was incorporated on 17 April 2018 (8+ years old) and is registered under LLPIN AAM-4384.

Requiron Medtech has 2 current designated partners:

The latest financial statements of Requiron Medtech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 March 2025. Year-wise statements from FY 2019 are in the company report.

The LLPIN (Limited Liability Partnership Identification Number) of Requiron Medtech is AAM-4384. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.

Requiron Medtech was incorporated on 17 April 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.

Aashima Chander was appointed as Partner on 19 Feb 2024. Abhishek Chander was appointed as Designated Partner on 19 Feb 2024. Atula Nayar was appointed as Partner on 19 Feb 2024. Requiron Medtech has 10 designated partner changes on record in total.

The registered office of Requiron Medtech is at F – 11 SF 2nd Floor East Of Kailash Near Big Apple, New Delhi, Delhi, India – 110065.

Requiron Medtech operates in the healthcare industry, in the medical and laboratory equipment segment.

Requiron Medtech has open charges of ₹1 Cr and no satisfied charges on record as per latest MCA filings.

Requiron Medtech can be reached at its registered office: F – 11 SF 2nd Floor East Of Kailash Near Big Apple, New Delhi, Delhi, India – 110065.